Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Impact van GBA1-varianten op klinische progressie bij Parkinson
mei 2020 | Bewegingsstoornissen